Skip to main content

New Medical Advances Can Slow Alzheimer's Profression: Facts for Dentists

Tracking # 20-1363286

$25.99

5 (3 ratings)
CE Broker Reporting Reported automatically
Method Computer-Based Training

What you'll learn

Following this course, course participants will be able to:

  1. Have a better understanding about biomarkers that enable early AD diagnosis, track disease progression, and assess therapeutic efficacy in clinical trials.
  2. Describe the role of plaques and tangles in Alzheimer’s disease.
  3. Have a better understanding about FDA approved blood tests to identify early onset AD.
  4. Comprehend and discuss FDA approved infusion treatments to slow AD's progression.
  5. Comprehend and discuss pros and cons of Kinsula and Leqembi.

Course overview

This 3-hour course examines many of the latest medical advances including biomarkers that enable early diagnosis, track disease progression, and assess therapeutic efficacy in clinical trials; FDA-cleared blood tests for identifying AD at early stages; FDA approved infusion treatments to slow AD progression; pros and cons of new treatments; and additional topics being researched.

Subject areas

This course counts toward the state boards and subject areas below.

Florida Board of Dentistry

Dental Hygienist

3h General

Dental Temporary Certificate

3h General

Dentist

3h General

Health Access Dentist

3h General

Disclosure statements

Take it Here

  • This course reports to CE Broker immediately upon completion.
  • Complete all courses at your own pace online.
  • Quality and enjoyable courses.
  • Modern experience, accessible from any device. 
  • All courses affordably priced.

Learner Feedback